Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
Go back to Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies| Gilead Sciences (NASDAQ: GILD) | Delayed: 145.71 -0.93 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.64 | 52 Week High | $108.63 | |||
| Open | $145.46 | 52 Week Low | $71.39 | |||
| Day High | $147.68 | P/E | 80.50 | |||
| Day Low | $145.00 | EPS | $1.81 | |||
| Volume | 1,402,259 | |||||
| (NYSE: RCUS) | Delayed: 28.27 -0.79 (2.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.06 | 52 Week High | $ | |||
| Open | $28.71 | 52 Week Low | $ | |||
| Day High | $29.30 | P/E | N/A | |||
| Day Low | $28.20 | EPS | $ | |||
| Volume | 760,582 | |||||

